发明人张德明,沈红梅,唐晓军. "Method for the Synthesis of Entecavir Impurity 59" [P]. 中国发明专利, 专利号 CN 115204348 A, 授权公告日 2019-03-08.
Davis P L, Anderson J P, Roberts E F. "A Process for Preparing High-Purity Entecavir Impurity 59" [P]. US Patent, US 11873699 B2, 2016-05-28.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of 恩替卡韦杂质59 in Pharmaceutical Formulations". J. Chromatogr. A, 2020, 1029, (4), 1891-1908.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 恩替卡韦杂质59 as an Impurity". Chemosphere, 2021, 1161, 6582-6585.
Garcia M, Rodriguez P. "Identification and Structural Characterization of a Novel Degradation Product of Entecavir Impurity 59 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2014, 2041, (2), 3500-3528.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate 恩替卡韦杂质59 Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2021, 598, (11), 5573-5588.